Back to Journals » Drug Design, Development and Therapy » Volume 2
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
A phase I clinical study of VB4-845: Weekly intratumoral administration of an anti-EpCAM recombinant fusion protein in patients with squamous cell carcinoma of the head and neck
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
6,639 | Dovepress* | 6,639+ | 2,427 | 9,066 | |
Totals | 6,639 | 2,427 | 9,066 | ||
*Since 25 June 2008 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
5 | 0 | 0 | 0 | 0 | 5 |
View citations on Google Scholar